Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Frontline Gastroenterology|September 4, 2020
Adult liver transplantation: A UK clinical guideline - part 1: pre-operationCharles Millson, Aisling Considine, Matthew E Cramp, et al.Transplantation|April 9, 2020
Paneth Cell Alterations During Ischemia-reperfusion, Follow-up, and Graft Rejection After Intestinal TransplantationAnna M Kip, Laurens J Ceulemans, Inca H R Hundscheid, et al.Annals of Surgery|November 29, 2007
The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registryJan P Lerut, Giuseppe Orlando, Rene Adam, et al.Journal of Clinical and Experimental Hepatology|March 23, 2023
National Liver Allocation Policy-Consensus Document by the Liver Transplantation Society of India for a Nationally Uniform System of Allocation of Deceased Donor Liver GraftsMettu S Reddy, Surendra K Mathur, Surendran Sudhindran, et al.Journal of Hepatology|July 19, 2015
Risk factors for recurrent primary sclerosing cholangitis after liver transplantationReena Ravikumar, Emmanuel Tsochatzis, Sophie Jose, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2021
The impact of advanced patient age in liver transplantation: a European Liver Transplant Registry propensity-score matching studyConcepción Gómez-Gavara, Chetana Lim, René Adam, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2020
Influence of donor and recipient gender on liver transplantation outcomes in EuropeGiacomo Germani, Nicola Zeni, Alberto Zanetto, et al.Alimentary Pharmacology & Therapeutics|December 19, 2018
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decadesMaren H Harms, Quisette P Janssen, Rene Adam, et al.The Lancet. Oncology|October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialBernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.Annals of Surgery|February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.Pageof 10